News

TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects ...
Tonix Pharmaceuticals (TNXP) presented data in an oral presentation at the World Vaccine Congress Washington 2025, held April 21-24, 2025, in ...
Most people in the U.S. have received vaccines to protect against infectious diseases. A vaccine against smallpox led to the ...
Emergent BioSolutions Inc.’s EBS share price has surged by 5.37%, which has investors questioning if this is right time to ...
But in 1796, Edward Jenner created the smallpox vaccine — the first successful vaccine to be developed. Today, thanks to the power of that vaccine, investments, action, and advocacy, smallpox was ...
The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...
In observance of World Immunisation Week, WHO's Saima Wazed emphasizes the importance of vaccines in protecting global health ...
Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system.
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...